Keywords: China Pharma, AstraZeneca, Rosuvstatin, Crestor, Cholesterol, China
China Pharma completes of trials of rosuvastatin planning to commercialize generic Crestor in domestic market
Article | 07 December 2010
Haikou City-based China Pharma Holdings (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, says it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
